NCT04047641
- Conditions
- Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, Hematologic Diseases, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Recurrent Acute Biphenotypic Leukemia
Explore clinical trials studying Recurrent Acute Biphenotypic Leukemia. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
Recurrent Acute Biphenotypic Leukemia trial results
NCT03326921
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
NCT04975919
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States